Abstract

Natural products are generally accepted by most industrial drug research organisations, but despite their incredible sustained track record and contribution to the pharmaceutical industries’ revenue streams, they are not fully appreciated. An improved integration of natural products into state-of-the-art drug research processes is only one of the options available. What changes must be made to improve the exploitation of nature’s diversity and where might natural products play a dominant role?

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.